FGF-21 alleviates diabetes-associated vascular complications: Inhibiting NF-κB/NLRP3 inflammasome-mediated inflammation?

International Journal of Cardiology

Volumn 185, Issue , 2015, Pages 320-321

  Liu, Mi Hua ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

FGF 21; Inflammation; NLRP3 inflammasome

Indexed keywords

CRYOPYRIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR 21; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; REACTIVE OXYGEN METABOLITE; ROSUVASTATIN; FIBROBLAST GROWTH FACTOR;

ATHEROSCLEROSIS; CELL PROTECTION; CELL SURVIVAL; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC CARDIOMYOPATHY; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG EFFECT; ENDOTHELIUM CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; INFLAMMATION; LETTER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REPERFUSION INJURY; ANIMAL; DIABETIC ANGIOPATHIES; IMMUNOLOGY; METABOLISM; MOUSE;

ANIMALS; DIABETIC ANGIOPATHIES; FIBROBLAST GROWTH FACTORS; HUMANS; INFLAMMASOMES; INFLAMMATION; MICE; NF-KAPPA B;

EID: 84928236637     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.165     Document Type: Article

References (19)

1. Y. Lin, and Z. Sun Current views on type 2 diabetes J. Endocrinol. 204 2010 1 11
2. G. Danaei, M.M. Finucane, Y. Lu, G.M. Singh, M.J. Cowan, and C.J. Paciorek National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants Lancet 378 2011 31 40
3. M.H. Liu, Z.H. Tang, G.H. Li, S.L. Qu, Y. Zhang, and Z. Ren Janus-like role of fibroblast growth factor 2 in arteriosclerotic coronary artery disease: atherogenesis and angiogenesis Atherosclerosis 229 2013 10 17
4. S. Kralisch, and M. Fasshauer Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease Curr. Opin. Clin. Nutr. Metab. Care 14 2011 354 359
5. A. Planavila, I. Redondo-Angulo, F. Ribas, G. Garrabou, J. Casademont, and M. Giralt Fibroblast growth factor 21 protects the heart from oxidative stress Cardiovasc. Res. 2014
6. X. Wu, Y.F. Qi, J.R. Chang, W.W. Lu, J.S. Zhang, and S.P. Wang Possible role of fibroblast growth factor 21 on atherosclerosis via amelioration of endoplasmic reticulum stress-mediated apoptosis in apoE mice Heart Vessels 2014
7. A. Planavila, I. Redondo, E. Hondares, M. Vinciguerra, C. Munts, and R. Iglesias Fibroblast growth factor 21 protects against cardiac hypertrophy in mice Nat. Commun. 4 2013 2019
8. Y. Lu, J.H. Liu, L.K. Zhang, J. Du, X.J. Zeng, and G. Hao Fibroblast growth factor 21 as a possible endogenous factor inhibits apoptosis in cardiac endothelial cells Chin. Med. J. (Engl.) 123 2010 3417 3421
9. X.M. Wang, S.S. Song, H. Xiao, P. Gao, X.J. Li, and L.Y. Si Fibroblast growth factor 21 protects against high glucose induced cellular damage and dysfunction of endothelial nitric-oxide synthase in endothelial cells Cell. Physiol. Biochem. 34 2014 658 671
10. K. Chen, J. Zhang, W. Zhang, J. Yang, K. Li, and Y. He ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy Int. J. Biochem. Cell Biol. 45 2013 932 943
11. B. Luo, B. Li, W. Wang, X. Liu, Y. Xia, and C. Zhang Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model Cardiovasc. Drugs Ther. 28 2014 33 43
12. L. Cai, Y. Wang, G. Zhou, T. Chen, Y. Song, and X. Li Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy J. Am. Coll. Cardiol. 48 2006 1688 1697
13. J.C. Simard, A. Cesaro, J. Chapeton-Montes, M. Tardif, F. Antoine, and D. Girard S100A8 and S100A9 induce cytokine expression and regulate the NLRP3 inflammasome via ROS-dependent activation of NF-kappaB(1.) PLoS One 8 2013 e72138
14. M. Bujak, and N.G. Frangogiannis The role of IL-1 in the pathogenesis of heart disease Arch. Immunol. Ther. Exp. (Warsz) 57 2009 165 176
15. S.M. Yang, S.M. Ka, H.L. Wu, Y.C. Yeh, C.H. Kuo, and K.F. Hua Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-kappaB/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis Diabetologia 57 2014 424 434
16. C. Zhang, M. Shao, H. Yang, L. Chen, L. Yu, and W. Cong Attenuation of hyperlipidemia- and diabetes-induced early-stage apoptosis and late-stage renal dysfunction via administration of fibroblast growth factor-21 is associated with suppression of renal inflammation PLoS One 8 2013 e82275
17. D.S. Bell Diabetes: a cardiac condition manifesting as hyperglycemia Endocr. Pract. 14 2008 924 932
18. C. Zhang, L. Zhang, S. Chen, B. Feng, X. Lu, and Y. Bai The prevention of diabetic cardiomyopathy by non-mitogenic acidic fibroblast growth factor is probably mediated by the suppression of oxidative stress and damage PLoS One 8 2013 e82287
19. M. Rajesh, S. Batkai, M. Kechrid, P. Mukhopadhyay, W.S. Lee, and B. Horvath Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy Diabetes 61 2012 716 727